Skip to content
Back to all posts

Microneedling Shows High Patient Satisfaction and Low Risk in Facial Rejuvenation

- In: Clinical Practice, Professional Development

As demand grows for non-surgical aesthetic procedures, microneedling (MN) has gained significant traction as a treatment for signs of facial aging. A recent systematic review and meta-analysis offer valuable insight into patient-reported outcomes and the safety profile of MN.

Study Overview
 Researchers conducted a systematic review in accordance with the PRISMA guidelines, evaluating 21 studies that involved 723 patients who underwent microneedling for facial rejuvenation. Most participants were women (72%), with an average age of 48.

Common Treatment Goals
 The studies focused on several key signs of facial aging, including:

  • Wrinkles (71%)

  • Skin texture (33%)

  • Photoaging (29%)

  • Skin laxity (14%)

Most patients received multiple sessions of microneedling, though the number and frequency of treatments varied across studies.

What Patients Reported
 The meta-analysis found that 83% of patients were satisfied with their results (95% CI [0.76–0.88]), reflecting a strong overall positive response to treatment.

Safety Profile
 Adverse events were generally mild and short-lived. The most commonly reported side effects included:

  • Transient redness (6.8%)

  • Scaling (1.7%)

  • Burning sensation (1.5%)

  • Itching (0.4%)

Conclusion
 Microneedling appears to be a safe and well-tolerated option for facial rejuvenation, with high levels of patient satisfaction and minimal side effects. However, the current lack of standardized outcome measures in aesthetic studies is a limitation that highlights the need for more consistent research to fully assess its long-term effectiveness in treating facial aging.

For a link to the original article, click here

Elevate-Derm Alliance Editorial Committee